BACK
HEALTHAUG 30, 2024

Common Blood Pressure Drug Extends Lifespan and Slows Aging

A PIECE BYWATSON EMY
SHARE:
article header
Health
A groundbreaking study shows that the common blood pressure drug Rilmenidine can increase lifespan and slow aging in animals. Researchers discovered that Rilmenidine reduces oxidative stress and enhances mitochondrial function, key factors in the aging process.

In a groundbreaking study, researchers have discovered that Rilmenidine, a common drug used to manage high blood pressure, can significantly extend lifespan and slow down the aging process in animals. This finding opens up exciting possibilities for drug repurposing in the fight against aging and age-related diseases.

Study Overview

The study, led by molecular biogerontologist Dr. João Pedro Magalhães from the University of Birmingham in the UK, and published in Nature Scientific Reports, explored the effects of Rilmenidine on various aging markers in animal models. The researchers aimed to understand how this drug, traditionally used to treat hypertension, could impact cellular aging processes, such as oxidative stress and mitochondrial function—both critical factors in aging and longevity.

Study Methodology

The research involved a cohort of middle-aged mice treated with Rilmenidine. The study was carefully controlled, with the mice being divided into two groups: one received Rilmenidine, while the control group did not.

Over several months, the researchers monitored key biomarkers of aging in the mice, including oxidative stress levels, telomere length, and mitochondrial function. These markers are critical indicators of biological aging, with longer telomeres and better mitochondrial health often associated with increased lifespan and improved overall health.

Key Findings

1. Prolonged Lifespan

The study found that mice treated with Rilmenidine exhibited a significant increase in lifespan compared to the control group. On average, the drug extended the mice's lifespan by 10-15%, which is a substantial improvement in the context of aging research.

Dr. Magalhães stated, "For the first time, we have been able to show in animals that Rilmenidine can increase lifespan. This discovery suggests that Rilmenidine could potentially be repurposed as an anti-aging treatment in humans."

2. Reduced Oxidative Stress

One of the key findings was the drug's ability to reduce oxidative stress in the animals. Oxidative stress, caused by an imbalance between free radicals and antioxidants in the body, is a major driver of aging and age-related diseases. By reducing oxidative stress, Rilmenidine helps protect cells from damage, thereby slowing the aging process.

3. Improved Mitochondrial Function

The study also demonstrated that Rilmenidine improved mitochondrial function in the mice. Mitochondria, often referred to as the powerhouses of the cell, play a crucial role in energy production. As organisms age, mitochondrial function tends to decline, leading to reduced energy levels and increased susceptibility to diseases. The drug’s ability to enhance mitochondrial health suggests a mechanism through which it can promote longevity.

Implications for Aging Research

These findings have significant implications for the field of aging research. The fact that Rilmenidine, a commonly prescribed blood pressure drug, can extend lifespan and improve healthspan in animals suggests that drug repurposing could be a viable strategy for developing anti-aging therapies in humans.

Potential for Human Application

While the study was conducted in mice, the researchers believe that Rilmenidine could have similar effects in humans, particularly in those already taking the medication for hypertension. However, further studies are needed to explore the drug's safety and efficacy in humans when used specifically for anti-aging purposes.

Future Research Directions

The promising results of this study have paved the way for future research into the potential of existing drugs to combat aging. The next steps will likely involve clinical trials in humans to confirm Rilmenidine’s efficacy and determine the optimal dosing regimen for anti-aging effects.

Moreover, researchers are also interested in exploring whether Rilmenidine could be combined with other treatments, such as caloric restriction or exercise, to further enhance its anti-aging effects.

Conclusion

This study marks a significant step forward in understanding how existing medications can be repurposed to extend lifespan and improve health during aging. By demonstrating that Rilmenidine can slow aging and increase lifespan in animal models, this research opens up new possibilities for using already-approved drugs in the fight against aging.

For more details on this study, you can read the full article published in Nature Scientific Reports here and the University of Liverpool's report here.


Related Articles

Cover Image
HEALTHJUN 14, 2025

What Is Diverticulosis? Most of Us Will Get It by Age 80

Most people will develop diverticulosis by age 80—and most don’t even know it. Learn what it is, why it happens, and how simple lifestyle changes like more fiber and movement can keep your gut healthy for the long haul

profile
Sohaib AliyaAUTHOR
Cover Image
HEALTHJUN 07, 2025

OTC Supplement May Halt Heart Disease in Type 2 Diabetes

A groundbreaking UK study presented at the British Cardiovascular Society conference reveals that the over-the-counter supplement mitoquinone could prevent heart failure in people with Type 2 diabetes. The clinical trial showed a 15% improvement in heart function with no side effects. The

profile
Ali IsrarAUTHOR
Cover Image
HEALTHMAY 31, 2025

Midlife Stress Hormone Linked to Alzheimer’s in Women

A study from UT Health San Antonio reveals that elevated cortisol levels during midlife are associated with increased brain amyloid deposits in postmenopausal women, a key marker for Alzheimer’s disease.

profile
Kon VivianAUTHOR
Cover Image
HEALTHMAY 25, 2025

Fiber-Based Gut Trick Burns Fat Fast in Mice

Fiber blend promoted the growth of butyrate-producing gut bacteria, which triggered fat-burning pathways & improved metabolism. Research suggests that nourishing microbiome with specific fermentable fibers could offer a powerful alternative to restrictive diets like keto for sustainable fat loss.

profile
Heinrich KatieAUTHOR
Cover Image
HEALTHMAY 18, 2025

Yogurt May Lower Colorectal Cancer Risk

A large-scale study published in JAMA Network Open finds that consuming yogurt at least twice a week may reduce the risk of developing Bifidobacterium-positive proximal colon cancer by up to 20%. Discover how this common breakfast food could support your long-term colon health.

profile
Thompson Anthony AUTHOR
Cover Image
HEALTHMAY 11, 2025

Low Vitamin K Linked to Faster Memory Decline

A new study published in The Journal of Nutrition reveals that low vitamin K intake may accelerate age-related memory decline by reducing neurogenesis and increasing inflammation in the brain. Researchers found that vitamin K deficiency disrupts brain structure and function.

profile
Ahsan AroojAUTHOR